PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III

This adverse event was reported 18 times

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LOMUSTINE 5 0.0019
1 CHLORAMBUCIL 5 0.0013
2 ETOPOSIDE 5 0.0001
3 DOXORUBICIN 5 0.0001
4 PREDNISOLONE ORAL SOLUTION 7 0.0000
5 CYCLOPHOSPHAMIDE FOR INJECTION 6 0.0000
6 CYCLOPHOSPHAMIDE 6 0.0000
7 RITUXIMAB 6 0.0000
8 ADALIMUMAB-FKJP 1 0.0000
9 ADALIMUMAB-AATY 1 0.0000
See all drugs enriched for association with PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III